#SDGAction32811
Intersectoral Forum to Fight NCDs in Brazil
Description

The ForumDCNTs was established as an initiative to build capacity for cross-sectoral dialogue and partnerships to address the threat of noncommunicable diseases (NCDs) in Brazil, guided by the SDG 17, to achieve the SDG 3.4 target of reducing premature mortality caused by NCDs by one third by 2030. Although several projects addressing NCDs exist in isolation, there has been no neutral ground in Brazil to facilitate collaboration and peer education between sectors to maximize impact with the goal of achieving sustainable and scalable solutions. The ForumDCNTs' biannual convenings are attended by ~50 leaders and authorities, so from: 6 public sector institutions (Federal Ministry of Health, Municipal and State Secretaries of Health and Universities), 14 health companies (pharma and medtech) and 23 not-for-profit organizations. During the morning period, the three sectors share knowledge and best practices of multisectoral programs and policies to fight NCDs; in the afternoon, workgroups share lessons and develop action plans to co-design or co-accelerate innovative strategies. Areas explored include: epidemiological updates, partnership building strategies, return-on-investment evaluations, public health priorities, and strategies for improving prevention and treatment of the main NCDs and their risk factors.

Moreover, the ForumDCNTs disseminates events, opportunities for partnerships, case studies, and facilitates access to resources through a monthly newsletter, webinars, Facebook page, Twitter (@ForumDCNTs), YouTube channel, LinkedIn group and website: www.ForumDCNTs.org

Two committee lead the initiative, the Organizing Committee and the Advisory Committee. In total, there are twelve active members from private, NGO, public and CSO representatives in the Committees.

Interestingly, more than 75% of the participants of biannual convenings are returning participants, all of them declare that the convening promos intersectoral dialogue and cooperation; 96% identify new partners during the convenings; 77.4% expresses motivation to engage in multisectoral partnerships between the convenings; and we have been observing an increase of 50% in the number of intersectoral projects in implementation phase between each convening.

In addition, the ForumDCNTs has already facilitated, for the first time in Brazil, the following achievements:
• NGOs united toward common goals and participation as a group at the UN High Level Meeting on NCDs in 2018;
• Public authorities committing to the sustainability of NCDs programs, proposed in conjunction with the private sector (e.g. diabetes and hypertension care programs in primary healthcare);
• Increased opportunities for the private and public sectors to participate in discussions with civil society (e.g. sugary drinks taxation);
• Foundation of an alliance for advocacy in cardiovascular care (GAC);
• Incorporation of additional themes in existing programs (e.g. mental disorders and hypercholesterolemia, hypertension and diabetes screening and referrals).

Expected impact

Reduce in 1/3 premature mortality caused by NCDs by 2030 (SDG 3.4), improving the Brazilian universal health coverage to guarantee equity.

Website

www.ForumDCNTs.org

Goal 3
Goal 17
Financing (in USD)
20 USD
Staff / Technical expertise
assistance in facilitating partnerships
Basic information
Start: 25 October, 2017
Completion: 31 December, 2030
Entity
Public Health Institute in Brazil (PHI-Brazil) (Non-governmental organization (NGO))
Partners
Secretaria Municipal da Saúde de São Paulo (local government), Secretaria Estadual da Saúde de São Paulo (local government), Secretaria Municipal da Saúde de Vitória da Conquista (local government), Ministério da Saúde (government), Universidade Federais da Bahia (academic institution), Universidade Federal de Minas Gerais (academic institution), FGV (academic institution) and Universidade de Sao Paulo (academic institution), Medtronic Foundation (philanthropic organization), Novartis Foundation (philanthropic organization), Associação Samaritano (philanthropic organization), Abbott (private sector), Amgen (private sector), AstraZeneca (private sector), Bayer (private sector), BD (private sector), Biomm (private sector), Itaú (private sector), Johnson & Johnson (private sector), Medtronic (private sector), MSD (private sector), Novo Nordisk (private sector), Pfizer (private sector), Roche (private sector), Sanofi (private sector), Servier (private sector), Takeda (private sector), Abrale/Abrasta (NGO), ACT Promoção da Saúde (NGO), ADJ Diabetes Brasil (NGO), Agita-SP/CELAFISCS (NGO), AHF (NGO), Amigos Múltiplos pela Esclerose (NGO), Artemisia (NGO), CIES Global (NGO), FENAD-ANAD (NGO), GRAACC (NGO), IDF-SACA (NGO), IEP-HSL (NGO), Instituto Desiderata (NGO), Instituto Oncoguia (NGO), Instituto Tellus (NGO), HIAE (NGO), PHI (NGO), Plan International Brasil (NGO), Sociedade Brasileira de Diabetes (scientific community) e Vital Strategies (NGO)
Geographical coverage
Latin America and the Caribbean
Beneficiary countries
Other beneficiaries
Contact information
Mark Thomaz Ugliara Barone, Dr., markbarone17@hotmail.com, 5511982093569
Headquarters
Sao Paulo, Brazil
United Nations